Zephyrnet Logo

Tag: Type 2 diabetes

Intarcia’s Diabetes Drug-Device Implant Unanimously Rejected by Adcomm | BioSpace

Pictured: People in suits with their thumbs down/iStock, iammotos The FDA’s Endocrinologic and Metabolic Drugs Advisory Committee on Thursday unanimously voted against Intarcia Therapeutics’...

Understanding PCOS: Symptoms, Risks, and Awareness – Seattle Clinical Research Center

September is Polycystic Ovary Syndrome (PCOS) Awareness Month, dedicated to spreading knowledge on this common yet often misunderstood health condition. PCOS affects millions of...

Medtronic Sued for Allegedly Sharing Health Info with Google – Knobbe Medical

Medtronic Minimed, Inc. and Minimed Distribution Corp. (“Medtronic”) were sued in a class action complaint in the Central District of California on August...

The Fit Stoner – Does Cannabis Spell the End of Diabetes and Better Metabolic Health for Regular Users?

The Fit Stoner: How Cannabis Correlates with Better Metabolic Health The classic image of lazy, gluttonous stoners gorging on junk food on the couch...

Battling Obesity: The Silent Epidemic and its Health Ramifications

Obesity, a chronic condition characterized by increased body fat, has emerged as a global health crisis. Data from 2017-2018 estimate that approximately 42% of...

Threads of Change: Unraveling the Obesity Epidemic – North Georgia Clinical Research

In the United States, obesity has surged to the forefront of health concerns, with the Southern region shouldering the highest rates in the country....

The impact of increasing ill health on the UK NHS services

<!-- --> In an era of significant medical progress, the National Health Service (NHS) faces a formidable challenge:...

A Journey of Challenges, Successes, and Understanding Type 2 Diabetes – BioPharma Services

A Journey of Challenges, Successes, and Understanding Type 2 Diabetes In 2022, BioPharma Services undertook its first...

Diabetes drug could promote healthy aging

A research team from the School of Public Health, LKS Faculty of Medicine of the University of Hong Kong (HKUMed), has provided genetic evidence...

New chronic kidney disease treatment option approved in EU

The first SGLT2 inhibitor to demonstrate a statistically significant reduction in all-cause hospitalisations in chronic kidney disease (CKD) patients versus placebo has been approved...

High-risk heart disease patients are declining statin therapy – Bio.News

Heart disease remains the leading cause of death in the United States. According to the American Heart Association (AHA), in 2020, cardiovascular disease (CVD)...

Weight Loss

In recent years, the prevalence of diabetes has been steadily increasing worldwide. While various factors contribute to this alarming trend, one significant risk factor...

Latest Intelligence

spot_img
spot_img